BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang LL, Lu YM, Wang YH, Wang YF, Fang RF, Sai WL, Yao DF, Yao M. Carnitine palmitoyltransferase-II inactivity promotes malignant progression of metabolic dysfunction-associated fatty liver disease via liver cancer stem cell activation. World J Gastroenterol 2024; 30(47): 5055-5069 [PMID: 39713165 DOI: 10.3748/wjg.v30.i47.5055]
URL: https://www.wjgnet.com/1948-5204/full/v30/i47/5055.htm
Number Citing Articles
1
Min Xu, Tian-Tian Ruan, Hao Tang, Rong-Fei Fang, Wen-Li Sai, Qun Xie, Deng-Fu Yao, Min Yao. Up-regulated programmed cell death protein-1/its ligand 1 expression promotes metabolic dysfunction-associated steatotic liver disease malignant progressionWorld Journal of Gastrointestinal Oncology 2025; 17(5): 104842 doi: 10.4251/wjgo.v17.i5.104842
2
Hong Cai, Chun-Hui Yang, Peng Gao. Rethinking carnitine palmitoyltransferase II and liver stem cells in metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinomaWorld Journal of Gastroenterology 2025; 31(15): 104528 doi: 10.3748/wjg.v31.i15.104528